Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 6/2012

01-06-2012 | Original Paper

Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study

Authors: Ljiljana Markovic-Denic, Kristina Zivkovic, Aleksandar Lesic, Vesna Bumbasirevic, Emilija Dubljanin-Raspopovic, Marko Bumbasirevic

Published in: International Orthopaedics | Issue 6/2012

Login to get access

Abstract

Purpose

Venous thromboembolism (VTE) is a common complication of orthopaedic surgery in the industrialised world; though there may be variability between population groups. This study aims to define the incidence and risk factors for symptomatic VTE following primary elective total hip and knee arthoplasty surgery in a single centre in Eastern Europe.

Methods

This prospective study included 499 adult patients undergoing total hip and knee arthroplasty for symptomatic osteoarthritis over a two-year period at the Clinic of Orthopaedic Surgery and Traumatology, Belgrade.

Results

The overall rate of confirmed symptomatic VTE during hospitalisation was 2.6%. According to the univariate logistic regression, an age greater than 75 years (OR = 3.08; 95%CI = 1.01–9.65), a family history of VTE (OR = 6.61; 95% CI = 1.33–32.90), varicose veins (OR = 3.13; 95% CI = 1.03–9.48), and ischemic heart disease (OR = 4.93; 95% CI = 1.61–15.09) were significant risk factors for in-hospital VTE. A family history of VTE and ischemic heart disease were independent risk factors according to multivariate regression analysis. Preoperative initiation of pharmacological thromboprophylaxis (p = 0.03) and a longer duration of thromboprophylaxis (p = 0.001) were protective for postoperative DVT. Though thromboprophylaxis was safe, with very few patients suffering major haemorrhage or heparin-induced thrombocytopenia, there was a general reluctance by our local surgeons to use prolonged thromboprophylaxis.

Conclusion

VTE is common following hip and knee arthroplasty surgery. Orthopaedic patients with a family history of VTE, heart failure and coronary heart disease are at a considerable risk of thromboembolic complications in the postoperative period. There may be a role for preoperative thromboprophylaxis in addition to prolonged postoperative treatment.
Literature
1.
Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28:370–372PubMedCrossRef
2.
Fisher WD (2011) Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. Can J Surg 54:344–351PubMedCrossRef
3.
Geerts WH, Bergquist D, Pineo G, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl):381S–453SPubMedCrossRef
4.
Deitelzweig SB, McKean SC, Amin AN, Brotman DJ, Jaffer AK, Spyropoulos AC (2008) Prevention of venous thromboembolism in the orthopedic surgery patient. Cleve Clin J Med 75(3):S27–S36PubMedCrossRef
5.
Eriksson IB, Kakkar KA, Turpie GA, Gent M, Bandel TJ, Homering M et al (2009) Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg 91-B:636–644CrossRef
6.
Barrellier MT, Lebel B, Parienti JJ, Mismetti P, Dutheil JJ, Vielpeau C et al (2010) Short versus extended thromboprophylaxis after total knee arthroplasty: a randomized comparison. Thromb Res 6:e298–e304CrossRef
7.
Sugano N, Miki H, Nakamura N, Aihara M, Yamamoto K, Ohzono K (2009) Clinical efficacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population. J Arthroplasty 24:1254–1257PubMedCrossRef
8.
Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 358:9–15PubMedCrossRef
9.
Memtsoudis GS, Besculides CM, Gaber L, Liu S, Gonzales Della Valle A (2009) Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study. Int Orthop (SICOT) 33:1739–1745CrossRef
10.
O’Donnell M, Linkins L-A, Kearon C, Julian J, Hirsh J (2003) Reduction of out-of-hospital symptomatic venous thromboembolism by extended thromboprophylaxis with low-molecular-weight heparin following elective hip arthroplasty. A systematic review. Arch Intern Med 163:1362–1366PubMedCrossRef
11.
Warvick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G et al (2007) Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacment when compared with the time course of thromboembolic events. J Bone Joint Surg Br 89-B:799–807CrossRef
12.
Samama CM, Vray M, Barre J, Fiessinger JN, Rosencher N, Lecompte T et al (2002) Extended venous thromboemblism prophylaxis after total hip replacement: a comparison of low- molecular-weight heparin with oral anticoagulant. Arch Intern Med 162:2191–2196PubMedCrossRef
13.
Mauermann WJ, Shilling AM, Zuo Z (2006) A comparison of neuroaxial block versus general anesthesia for elective total hip replacement: a meta analysis. Anesth Analg 103:1018–1025PubMedCrossRef
14.
Macfarlane AJR, Prasad GA, Chan VWS, Brull R (2009) Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth 103:335–345PubMedCrossRef
15.
Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J et al (2008) Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a doubleblind, randomised controlled trial. Lancet 372:29–37CrossRef
16.
Fuji T, Fujita S, Takahiro Ochi T (2008) Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. Int Orthop 32:443–451PubMedCrossRef
17.
Samama CM, Ravaud P, Parent F, Barre J, Mertl P, Mismetti P (2007) Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost 5:2360–2367PubMedCrossRef
18.
Anderson FA Jr, Hirsh J, White K, Fitzgerald RH Jr, Hip and Knee Registry Investigators (2003) Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry. Chest 124(6 Suppl):349–356
19.
Sen RK, Kumar A, Tripathy SK, Aggarwal S, Khandelwal N, Manoharan SR (2011) Risk of postoperative venous thromboembolism in Indian patients sustaining pelvi-acetabular injury. Int Orthop 35:1057–1063PubMedCrossRef
20.
Friedman RJ, Gallus AS, Cushner FD, FitzGerald G, Anderson FA Jr; Global Orthopaedic Registry Investigators (2008) Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr Med Res Opin 24:87–97
21.
Spyropoulos AC, Hussein M, Lin J, Battleman D (2009) Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study. J Thromb Thrombolysis 28:458–464PubMedCrossRef
22.
Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL (2003) Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology 99:552–560PubMedCrossRef
23.
Arcelus JI, Monreal M, Caprini JA, Guisado G, Jose Soto M, Nunez MJ et al (2008) Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Thromb Haemost 99:46–551
24.
White RH, Henderson MC (2002) Risk factors for venous thromboembolism after total hip or knee replacement surgery. Curr Opin Pulm Med 8:365–371PubMedCrossRef
25.
Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet 358:91–95CrossRef
Metadata
Title
Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study
Authors
Ljiljana Markovic-Denic
Kristina Zivkovic
Aleksandar Lesic
Vesna Bumbasirevic
Emilija Dubljanin-Raspopovic
Marko Bumbasirevic
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 6/2012
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-011-1466-5

Other articles of this Issue 6/2012

International Orthopaedics 6/2012 Go to the issue

Original Paper

Causes of a painful total knee arthroplasty. Are patients still receiving total knee arthroplasty for extrinsic pathologies?

Review Article

Lumbar paraspinal compartment syndrome

Original Paper

Polyethylene thickness is a risk factor for wear necessitating insert exchange

Original Paper

Monitoring the one year postoperative infection rate after primary total hip replacement

Original Paper

Bone mineral density is not related to heterotopic ossification after total hip arthroplasty

Original Paper

Hip joint development in children with type IIb developmental dysplasia